English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

ACEI,:   angiotensin converting enzyme inhibitorsAF,:   atrial fibrillationARB,:   angiotensin receptor blockersAVNRT,:   atrioventricular nodal re-entry tachycardiaBMI,:   body mass indexCHADS2,:   cardiac failure, hypertension, age, diabetes, stroke (doubled)CHA2DS2-VASc,:   congestive heart failure or left ventricular dysfunction, hypertension, age ≥75 (doubled), diabetes, stroke/transient ischaemic attack (doubled)-vascular disease, age 65–74, sex category (female)CI,:   confidence intervalFU,:   follow-upHR,:   hazard ratioHDL,:   high-density lipoprotein cholesterolICD,:   implantable cardioverter defibrillatorsLA,:   left atriumLDL,:   low-density lipoprotein cholesterolLV,:   left ventricleNOAC,:   non-VKA oral anticoagulantOAC,:   oral anticoagulationOR,:   odds ratioOSA,:   obstructive sleep apnoean 3-PUFA,:   ω-3 polyunsaturated fatty acidsRAAS,:   renin–angiotensin–aldosterone systemRR,:   relative riskSBP,:   systolic blood pressureSAMe-TT2R2,:   sex (female), age (u003c60 years), medical history, treatment (interacting drugs, e.g. amiodarone for rhythm control), tobacco use (within 2 years) (doubled), Race (non-Caucasian) (doubled)SVT,:   supraventricular tachyarrhythmiaVKA,:   vitamin K antagonistAtrial fibrillation (AF) is an important and highly prevalent arrhythmia, which is associated with significantly increased morbidity and mortality, including a four- to five-fold increased risk for stroke,1,2 a two-fold increased risk for dementia,3,4 a three-fold risk for heart failure,2 a two-fold increased risk for myocardial infarction,5,6 and a 40–90% increased risk for overall mortality.2,7 The constantly increasing number of AF patients and recognition of increased morbidity, mortality, impaired quality of life, safety issues, and side effects of rhythm control strategies with antiarrhythmic drugs, and high healthcare costs associated with AF have spurred numerous investigations to develop more effective treatments for AF and its complications.8 Although AF treatment has been studied extensively, AF prevention has received relatively little attention, while it has paramount importance in the prevention of morbidity and mortality, and complications associated with arrhythmia and its treatment. Current evidence shows a clear association between the presence of modifiable risk factors and the risk of developing AF.By implementing AF risk reduction strategies aiming at risk factors such as obesity, hypertension, diabetes, and obstructive sleep apnoea (OSA), which are interrelated, we impact upon the escalating …

europace

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)